Work

Development of a Scalable Process for TNG348: A Potent, Selective, and Orally Bioavailable USP1 Inhibitor

Year: 2026

Type: article

Source: Organic Process Research & Development

DOI: 10.1021/acs.oprd.5c00492

Authors: Jianglin Colin Liang, Jianbin Zhang, Luigi Anzalone, Scott Throner, Yong Liu, Michael A. Palmieri

Institution: Tango Therapeutics (United States)

Language: English

Topic: Chemical Synthesis and Analysis

Subfield: Molecular Biology

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

Open Access status: closed

OpenAlex ID: W7155195747

FWCI:

Cites: 25

Cited by:

Related to: